Ascletis Pharma Inc.

Investors

2024

2023

2022

2021

2020

2019

2018

Poll Results of Annual General Meeting Held on June 15 2020
2020-06-15
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
2020-06-02
Clarification Announcement - Form of Proxy for the 2020 Annual General Meeting
2020-05-28
Voluntary Announcement - Approval of Clinical Trials of Non-alcoholic Steatohepatitis Drug ASC41, a THR-beta Agonist
2020-05-13
Notification Letter to Non-Registered Holders of Shares with Request Form - Notice of Publication of Circular containing Notice of Annual General Meeting
2020-05-13
Form of Proxy for the 2020 Annual General Meeting
2020-05-13
Notice of 2020 Annual General Meeting
2020-05-13
Proposals for General Mandates to Issue Shares and to Repurchase Shares, Re-election of Retiring Directors and Notice of Annual General Meeting
2020-05-13
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
2020-05-06
Notification Letter to Non-Registered Holders of Shares with Request Form - Notice of Publication of Annual Report 2019
2020-04-22

5

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1